Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | glycogen phosphorylase | 0.0915 | 0.3826 | 0.5 |
Loa Loa (eye worm) | TK/ALK protein kinase | 0.1753 | 0.9996 | 1 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0915 | 0.3826 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1536 | 0.8398 | 0.7411 |
Mycobacterium tuberculosis | Probable glycogen phosphorylase GlgP | 0.0396 | 0 | 0.5 |
Chlamydia trachomatis | glycogen phosphorylase | 0.0915 | 0.3826 | 0.5 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0915 | 0.3826 | 1 |
Schistosoma mansoni | glycogen phosphorylase | 0.0915 | 0.3826 | 1 |
Mycobacterium ulcerans | glycogen phosphorylase GlgP | 0.0396 | 0 | 0.5 |
Onchocerca volvulus | Glycogen phosphorylase homolog | 0.0915 | 0.3826 | 0.5 |
Echinococcus granulosus | glycogen phosphorylase | 0.0915 | 0.3826 | 0.5 |
Echinococcus multilocularis | glycogen phosphorylase | 0.0915 | 0.3826 | 0.5 |
Giardia lamblia | Glycogen phosphorylase | 0.0915 | 0.3826 | 0.5 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0915 | 0.3826 | 0.5 |
Echinococcus granulosus | Glycosyl transferase family 35 | 0.0915 | 0.3826 | 0.5 |
Schistosoma mansoni | glycogen phosphorylase | 0.0915 | 0.3826 | 1 |
Echinococcus multilocularis | glycogen phosphorylase | 0.0915 | 0.3826 | 0.5 |
Echinococcus multilocularis | Glycosyl transferase, family 35 | 0.0915 | 0.3826 | 0.5 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0915 | 0.3826 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Drug uptake (ADMET) | = 2.89 % ID/g | Biodistribution in mouse brain at 60 mins | ChEMBL. | 23601814 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.